Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-12-31
1988-04-12
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540226, A61K 31545, C07D50136
Patent
active
047374926
ABSTRACT:
The hydrabamine and benzathine salts of cefamandole are useful in aqueous ophthalmic compositions which have good stability and shelf life.
REFERENCES:
patent: 2627491 (1953-02-01), Szabo et al.
patent: 2812326 (1957-11-01), De Rose
patent: 3641021 (1972-02-01), Ryan
patent: 4529720 (1985-07-01), Cole et al.
Gerson Steven H.
Han Wesley W.
Alcon Laboratories Inc.
Arno James A.
Brown Gregg C.
Daus Donald G.
Teoli, Jr. William A.
LandOfFree
Sparingly soluble salts of cefamandole, and ophthalmic compositi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sparingly soluble salts of cefamandole, and ophthalmic compositi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sparingly soluble salts of cefamandole, and ophthalmic compositi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1429508